Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.
Michelle Olofsson, Walter Osika, Simon B. Goldberg, Peter S. Hendricks, Predrag Petrović, Tonya White, Cecilia U.D. Stenfors, Sankalp Chaturvedi, Otto Simonsson
International Journal of Drug Policy December 13, 2025 DOI: 10.1016/j.drugpo.2025.105105 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional mixed-methods study Qualitative Peer reviewed |
|---|---|
| Sample size | 3,168 |
| Population | U.S. adults with lifetime psychedelic use |
| Citations | 2 |
| Key findings | Childhood adversity is associated with higher odds of psychedelic-related difficulties, including persistent symptoms lasting more than one day or one week. |
Abstract
Background: Naturalistic psychedelic use can result in a range of difficulties that impair social, occupational, and other important areas of functioning. Yet, the prevalence, phenomenology, and etiology of these outcomes remain poorly understood. Recent qualitative research has shown that individuals with long-term difficulties after psychedelic use sometimes attribute their challenges to childhood trauma. Further studies are needed to investigate these relationships.
Methods: In this cross-sectional mixed-methods study of U.S. adults with lifetime psychedelic use (n = 3168), we examined the prevalence, duration, and nature of psychedelic-related difficulties, as well as associations with adverse childhood experiences (ACEs).
Results: Of all participants (n = 3168), most (n = 2785, 87.9 %) reported no difficulties; 6.4 % (n = 203) reported post-acute difficulties that lasted for more than one day, and 1.3 % (n = 40) for more than one year. Among those who reported difficulties (n = 383), 47 % (n = 180) reported that their difficulties resolved in one day or less. The most frequently reported post-acute difficulties were general anxiety (33.9 %), negative changes in self-concept (25.9 %), and social disconnection (23.0 %). In covariate-adjusted regression models, 2 ACEs (aOR: 2.24, p = 0.007), 3 ACEs (aOR: 2.27, p = 0.006), and ≥4 ACEs (aOR: 2.84, p < 0.001) were associated with higher odds of psychedelic-related difficulties compared to 0 ACEs. ≥4 ACEs were also associated with higher odds of difficulties that lasted more than one day (aOR: 2.37, p = 0.015) and more than one week (aOR: 2.89, p = 0.042).
Conclusion: There are a range of difficulties that can follow psychedelic use and childhood adversity may represent a risk factor for persistent adverse effects.
Citations in the library
Cited by 6
- Extended difficulties after psychedelic experiences: Prevalence and associations in a global, multilingual sample. Research Square April 8, 2026
- Safety in an Evolving Psychedelic Landscape: Knowledge and Use of Psilocybin Safety Strategies, Resources, and Support in a Naturalistic Oregon Sample Psychedelics October 1, 2026
- Psychedelic Safety and Clinical Outcomes Across Exposure Patterns: A Structured Narrative Review Life August 14, 2026
- Changes in neuroticism and values after naturalistic use of psychedelics and MDMA: a prospective survey study Journal of Affective Disorders Reports July 1, 2026
- Post-traumatic stress disorder symptoms following psychedelic use: a naturalistic survey study Psychological Medicine 2026
and 1 more in the library
Cites 45
- Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression Journal of Humanistic Psychology June 19, 2017
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Journal of Psychopharmacology August 31, 2016
- Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects Biological Psychiatry November 29, 2014
- The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms Journal of Psychopharmacology November 18, 2016
- Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies Acta Psychiatrica Scandinavica October 30, 2020
and 40 more in the library